Olympus

Olympus Corporation finalized the acquisition of Medi-Tate Ltd., an Israeli medical device company specializing in minimally invasive treatment for benign prostatic hyperplasia (BPH). The acquisition expands Olympus's urology portfolio with the iTind device.

Olympus Corporation announced it has exercised its call option to acquire the remainder of shares in Medi-Tate Ltd., an Israeli medical device company specializing in minimally invasive treatment for benign prostatic hyperplasia. The acquisition aims to expand Olympus' urology business.

Olympus signed an agreement to acquire Veran Medical Technologies (VMT) through its subsidiary Olympus Corporation of the Americas for up to $340 million. The deal aims to strengthen Olympus' respiratory device portfolio by combining its endoscope technologies with VMT's electromagnetic navigation system for lung cancer diagnosis.

Olympus Corporation acquired FH ORTHO SAS, an international orthopedic company headquartered in Heimsbrunn, France, to expand its minimally invasive surgery field and reinforce its orthopedics business.

Olympus Corporation announced it has signed a definitive agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V., to expand its offering in gastrointestinal therapeutic devices and advanced colonoscopy tools.

Olympus Corporation announced an agreement to acquire Veran Medical Technologies, Inc., a provider of interventional pulmonology devices, for up to USD 340 million, through its subsidiary Olympus Corporation of the Americas.

Olympus entered into a final agreement with Medi-Tate Ltd., an Israeli medical device manufacturer, including distribution rights and an option to acquire 100% of the company. The investment strengthens Olympus's urology business.

Olympus Corporation has entered into a final agreement to invest in Israeli company Medi-Tate, including distribution rights and a call option to acquire 100% of the company.

Olympus signed a definitive agreement to acquire lithotripsy system design and production technology from Cybersonics, Inc., based in Erie, PA. The acquisition includes the ShockPulse-SE and CyberWand systems, which will be manufactured by Olympus Surgical Technologies America.

Olympus announced the grand opening of its expanded Bartlett campus in Tennessee, including a new National Service Center East and medical asset warehouse/distribution center. The $12 million, 110,000-square-foot facility started operations in October 2017 and is expected to create about 280 jobs.